Related by context. Frequent words. (Click for all words.) 73 AUXL 72 Guides FY# Quick Facts 72 QGEN 72 SGMO 71 AKRX 71 BMRN 71 THE TREND CONTINUES LOWER 70 THE TREND CONTINUES DOWN 70 AFFY 70 RPRX 70 BMTI 70 DOWNTREND SPOTTED IN SHARES 69 Calls Purchased 69 IART 69 THE TREND CONTINUES HIGHER 69 THE TREND CONTINUES UP 69 WEEK HIGH RECENTLY ECLIPSED 68 Options Trader Alert 68 IMMU 68 IMGN 68 DETECTS UNUSUAL ACTIVITY IN 68 ALNY 68 SHARES COULD PULLBACK 68 www.labopharm.com 68 SMARTREND 'S OPTION SCANNER 68 SHARES COULD POTENTIALLY PULLBACK 68 PRXL 68 AEterna Zentaris Inc. 68 REACHES INITIAL SUPPORT LEVEL 68 Forecast Quick Facts 67 SVNT 67 ISPH 67 Anika Therapeutics Inc. 67 Idera Pharmaceuticals 67 BREAKS THROUGH SUPPORT 67 DOWNWARD MOMENTUM LOOKS TO 67 ALTH 67 SEE CONTINUED DOWNWARD MOMENTUM 67 SCLN 67 Barrier Therapeutics Inc. 67 UPTREND SPOTTED IN SHARES 67 ZGEN 67 Stock Upgraded 67 POZN 67 Bullish Engulfing Pattern 67 OFFERS INVESTORS BETTER VALUE 67 CROSSES PIVOT POINT SUPPORT 67 VPHM 67 IGTE 67 INCY 67 OUT IN SHARES 67 Electro Optical Sciences 66 DYAX 66 CRME 66 Q3 Loss Narrows 66 Interesting Options Volume 66 UPWARD MOMENTUM LOOKS TO 66 NEXT SUPPORT LEVEL FOR 66 SMARTREND DETECTS CONTINUED SELLING 66 REGN 66 AVNR 66 VNDA 66 NBIX 66 SXCI 66 HXL 66 Sunesis Pharmaceuticals Inc. 66 % SELL OFF 66 PATTERN FOR 66 NASDAQ CRXL 66 APPROACHES NEW UPSIDE TARGET 66 APPROACHES NEW DOWNSIDE TARGET 66 BREAKS THROUGH RESISTANCE AT 66 CROSSES PIVOT POINT RESISTANCE 66 Lexicon Pharmaceuticals 66 Options Activity 66 NEXT RESISTANCE LEVEL FOR 66 SMARTREND DETECTS CONTINUED BUYING 65 SET TO PULLBACK AFTER 65 SET TO POSSIBLY PULLBACK 65 UTIW 65 CYBX 65 SMARTREND DETECTS POTENTIAL BREAK 65 EARNINGS UPDATE 65 ABOVE AVERAGE VOLUME 65 THE WINNING STREAK 65 HOLX 65 ONXX 65 Nymox Pharmaceutical Corporation 65 ARE MOVING HIGHER ON 65 Pluristem Therapeutics Inc. 65 Q2 Loss Narrows 65 HIGHER PRICES ON #.#X 65 CYTX 65 ISTA Pharmaceuticals 65 #/#/# PriceWatch Alert Technicals [001] 65 NovaBay Pharmaceuticals Inc. 65 YESTERDAY 'S SELLOFF OF 65 Q1 Loss Narrows 65 INSU 65 MiddleBrook Pharmaceuticals Inc. 65 Alseres Pharmaceuticals Inc.